losartan has been researched along with Absence Status in 5 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| "Spontaneous seizures were video- and EEG-monitored in spontaneously hypertensive rats (SHRs) for a 16-week period after SE." | 5.43 | Long-Term Treatment with Losartan Attenuates Seizure Activity and Neuronal Damage Without Affecting Behavioral Changes in a Model of Co-morbid Hypertension and Epilepsy. ( Atanasova, D; Ivanova, N; Kortenska, L; Lazarov, N; Lozanov, V; Mitreva, R; Pechlivanova, DM; Stoynev, A; Tchekalarova, JD, 2016) |
| "Spontaneous seizures were video- and EEG-monitored in spontaneously hypertensive rats (SHRs) for a 16-week period after SE." | 1.43 | Long-Term Treatment with Losartan Attenuates Seizure Activity and Neuronal Damage Without Affecting Behavioral Changes in a Model of Co-morbid Hypertension and Epilepsy. ( Atanasova, D; Ivanova, N; Kortenska, L; Lazarov, N; Lozanov, V; Mitreva, R; Pechlivanova, DM; Stoynev, A; Tchekalarova, JD, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bar-Klein, G | 1 |
| Lublinsky, S | 1 |
| Kamintsky, L | 1 |
| Noyman, I | 1 |
| Veksler, R | 1 |
| Dalipaj, H | 1 |
| Senatorov, VV | 1 |
| Swissa, E | 1 |
| Rosenbach, D | 1 |
| Elazary, N | 1 |
| Milikovsky, DZ | 1 |
| Milk, N | 1 |
| Kassirer, M | 1 |
| Rosman, Y | 1 |
| Serlin, Y | 1 |
| Eisenkraft, A | 1 |
| Chassidim, Y | 1 |
| Parmet, Y | 1 |
| Kaufer, D | 1 |
| Friedman, A | 1 |
| Hong, S | 1 |
| JianCheng, H | 1 |
| JiaWen, W | 1 |
| ShuQin, Z | 1 |
| GuiLian, Z | 1 |
| HaiQin, W | 1 |
| Ru, Z | 1 |
| Zhen, G | 1 |
| HongWei, R | 1 |
| Sun, H | 1 |
| Wu, H | 1 |
| Yu, X | 1 |
| Zhang, G | 1 |
| Zhang, R | 1 |
| Zhan, S | 1 |
| Wang, H | 1 |
| Bu, N | 1 |
| Ma, X | 1 |
| Li, Y | 1 |
| Tchekalarova, JD | 1 |
| Ivanova, N | 1 |
| Atanasova, D | 1 |
| Pechlivanova, DM | 1 |
| Lazarov, N | 1 |
| Kortenska, L | 1 |
| Mitreva, R | 1 |
| Lozanov, V | 1 |
| Stoynev, A | 1 |
| Tsai, CY | 1 |
| Chan, JY | 1 |
| Hsu, KS | 1 |
| Chang, AY | 1 |
| Chan, SH | 1 |
5 other studies available for losartan and Absence Status
| Article | Year |
|---|---|
Imaging blood-brain barrier dysfunction as a biomarker for epileptogenesis.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Angiotensin II Type 1 Receptor Blockers; Animals; B | 2017 |
Losartan inhibits development of spontaneous recurrent seizures by preventing astrocyte activation and attenuating blood-brain barrier permeability following pilocarpine-induced status epilepticus.
Topics: Animals; Astrocytes; Blood-Brain Barrier; Brain; Disease Models, Animal; Epilepsy; Losartan; Male; N | 2019 |
Angiotensin II and its receptor in activated microglia enhanced neuronal loss and cognitive impairment following pilocarpine-induced status epilepticus.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cognition Disorders; Hippocampus; | 2015 |
Long-Term Treatment with Losartan Attenuates Seizure Activity and Neuronal Damage Without Affecting Behavioral Changes in a Model of Co-morbid Hypertension and Epilepsy.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Hippocampus; Hypertension; Losartan; Male; Neuron | 2016 |
Brain-derived neurotrophic factor ameliorates brain stem cardiovascular dysregulation during experimental temporal lobe status epilepticus.
Topics: Acetophenones; Animals; Antioxidants; Brain Stem; Brain-Derived Neurotrophic Factor; Cardiovascular | 2012 |